CBD Research and Colitis and Crohn’s Disease

• CBD in inflammatory bowel diseases: a brief overview
• Cannabis finds its way into treatment of Crohn’s disease
• CBD reduces intestinal inflammation through the control of neuroimmune axis
• Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis
• The effects of Delta-tetrahydrocannabinol and CBD alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis
• Topical and systemic cannabidiol improves trinitrobenzene sulfonic acid colitis in mice
• Cannabinoids and the gut: New developments and emerging concepts
• Endocannabinoids and the gastrointestinal tract
• Cannabinoids and gastrointestinal motility: Animal and human studies
• Hergenrather presents study of Crohn’s patients as a template for clinical research on Cannabis